CCL2 Can Recruit M2 Type Macrophages To Inhibit The Effector Function And Anti-Tumor Effect Of CD8+ T Cells And Promote The Development Of NSCLC. This evidence concerns the gene CD8A and non-small cell lung carcinoma.